The Global Blood Bags market is expected to reach $5,269.72million by 2026 growing at a CAGR of 5.6% during 2018 to 2026.

The key vendors mentioned are Wego, Terumo, Stt, Neomedic, Macopharma, Jms, Haemonetics, Grifols, Fresenius, and Advacare.

— he blood bags are essential to store blood and its components as the blood are very sensitive to temperature, light, and air. The blood bags prevent the blood from coagulation and contamination. The rise in demand for the sterilized process of transport and transfusion of blood and its mechanism are some of the factors driving the market growth. However, the hazardous waste produced by the extreme handling of blood bags is hampering market growth.

Access the complete report at:[1]

Based on Type, Transfer bags are constructed of PVC and are obtainable in a variety of sizes and configurations. Blood transfer bags for sterilized protection and management of blood mechanism to aid blood security.

Make an inquiry at:[2]

Types Covered:
• Transfer Bags
• Citrate-Phosphate-Dextrose-Adenine (CPDA) Blood Bags
• Citrate Phosphate Dextrose/Saline-Adenine-Glucose-Mannitol (CPD/SAGM) Blood Bags
• Other Types

Products Covered:
• Triple
• Single
• Quadruple
• Double
• Other Products

Capacity Types Covered:
• 700 ml – 1000 ml
• 450 ml – 700 ml
• 250 ml -450 ml
• 100 ml – 250 ml
• 0 ml – 100 ml
• Other Capacity Types

Channels Covered:
• Distributor
• Direct Sales

End Users Covered:
• Non-Governmental Organizations
• Hospital
• Diagnostic Centers
• Clinical Research
• Blood Banks
• Other End Users

Regions Covered:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Learn more about Syngeneresearch here:[3]

Key Questions Answered in this Report:
• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analyzed during the forecast period

1 2